Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy

Category Primary study
JournalClinical Ophthalmology
Year 2012
This article has no abstract
Epistemonikos ID: 49067100d304b48cb9a1a30bcc6bb786389bffa4
First added on: Feb 05, 2025